MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-30-2025
Country |
 USA |
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
1.74 B |
Market Cap[1] |
$ 218 B |
EBITDA (LTM) |
$ 8.77 B |
P/E (LTM) |
35.66 |
P/S (LTM) |
5.05 |
EPS (LTM) |
3.46 |
Abbott Laboratories is a global healthcare company founded in 1888. The company develops and manufactures a wide range of medical devices, diagnostics, and nutritional products. Abbott's products and services are used by healthcare professionals and patients in over 160 countries.
Abbott is known for its innovative solutions for healthcare challenges. The company invests heavily in research and development to develop new products and technologies that improve patient outcomes and reduce healthcare costs. Abbott's areas of focus include cardiovascular, diabetes care, diagnostic imaging, infectious diseases, nutrition, and pharmaceuticals.
Abbott is committed to social responsibility and sustainability. The company aims to reduce its environmental impact and promote the use of renewable energy. Abbott also supports community health initiatives and disaster relief efforts around the world.
Overall, it's a significant player in the healthcare industry, with a strong commitment to innovation, quality, and sustainability. The company's products and services have a significant impact on patient outcomes and the global healthcare system.
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Apyx Medical Corporation
APYX
|
$ 3.86 | -3.26 % | $ 134 M | Nasdaq Global Select Market | USA |
 |
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | USA |
 |
Abiomed
ABMD
|
- | - | $ 17.2 B | Nasdaq Global Select Market,SPB | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | USA |
 |
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | USA |
 |
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market |  China |
 |
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | USA |
 |
Bio-Rad Laboratories
BIO
|
$ 307.92 | -1.93 % | $ 8.69 B | NYSE,SPB | USA |
 |
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | USA |
 |
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | USA |
 |
Bruker Corporation
BRKR
|
$ 45.13 | -2.67 % | $ 6.72 K | Nasdaq Global Select Market,SPB | USA |
 |
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | USA |
 |
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | USA |
 |
Boston Scientific Corporation
BSX
|
$ 92.34 | 0.64 % | $ 136 B | NYSE,SPB | USA |
 |
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | USA |
 |
EDAP TMS S.A.
EDAP
|
$ 2.56 | 8.94 % | $ 95.5 M | Nasdaq Global Market |  France |
 |
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | USA |
 |
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | USA |
 |
IRIDEX Corporation
IRIX
|
$ 0.92 | -4.72 % | $ 14.8 M | Nasdaq Global Select Market | USA |
 |
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | USA |
 |
IRadimed Corporation
IRMD
|
$ 96.35 | -1.06 % | $ 1.22 B | Nasdaq Global Select Market | USA |
 |
OrthoPediatrics Corp.
KIDS
|
$ 17.7 | -3.46 % | $ 408 M | Nasdaq Global Select Market,SPB | USA |
 |
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | USA |
 |
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market |  Israel |
 |
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | USA |
 |
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market |  Canada |
 |
LivaNova PLC
LIVN
|
$ 62.79 | -1.82 % | $ 3.41 B | Nasdaq Global Select Market |  Britain |
 |
Pulmonx Corporation
LUNG
|
$ 2.53 | 0.86 % | $ 99 M | Nasdaq Global Select Market | USA |
 |
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | USA |
 |
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | USA |
 |
InMode Ltd.
INMD
|
$ 14.56 | 0.76 % | $ 1.15 B | Nasdaq Global Select Market,SPB | Israel |
 |
Cognyte Software Ltd.
CGNT
|
$ 9.88 | 0.05 % | $ 709 M | Nasdaq Global Select Market,SPB | Israel |
 |
Myomo
MYO
|
$ 1.06 | -1.85 % | $ 7.47 M | NYSE American | USA |
 |
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
$ 13.41 | -4.56 % | $ 1.03 B | Nasdaq Global Select Market,SPB | USA |
 |
NuVasive
NUVA
|
- | - | $ 2.07 B | Nasdaq Global Select Market,SPB | USA |
 |
Align Technology
ALGN
|
$ 165.15 | 0.78 % | $ 12.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Accuray Incorporated
ARAY
|
$ 1.07 | -3.18 % | $ 110 M | Nasdaq Global Select Market | USA |
 |
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | USA |
 |
ClearPoint Neuro
CLPT
|
$ 12.81 | -1.23 % | $ 346 M | Nasdaq Capital Market | USA |
 |
Orthofix Medical
OFIX
|
$ 15.51 | -1.27 % | $ 591 M | Nasdaq Global Select Market,SPB |  Curacao |
 |
FONAR Corporation
FONR
|
$ 14.86 | -0.03 % | $ 97.4 M | Nasdaq Capital Market | USA |
 |
AxoGen
AXGN
|
$ 30.33 | 1.15 % | $ 1.34 B | Nasdaq Capital Market,SPB | USA |
 |
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | USA |
 |
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | USA |
 |
CONMED Corporation
CNMD
|
$ 40.78 | 2.33 % | $ 1.26 B | NYSE,SPB | USA |
|
LENSAR
LNSR
|
$ 11.48 | -0.17 % | $ 132 M | Nasdaq Capital Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.